ArticleFrontiers in oncology2023

High-throughput drug screening identifies fluoxetine as a potential therapeutic agent for neuroendocrine prostate cancer.

Lei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.